News | December 31, 2023
Roche to buy LumiraDx’s technology platform for US$ 295 million
Roche will pay a purchase price of USD 295 million and an additional payment of up to USD 55 million
Roche will pay a purchase price of USD 295 million and an additional payment of up to USD 55 million
Sirius JV will be owned 51% by Sirius and 49% by Adani
MedTech Mitra is a platform that will help the young talents of the country by holding their hands and giving them final shape to their research, knowledge and logic
Furthering cell therapy ambition across oncology and autoimmune diseases
If approved, Xolair would be the first medicine to reduce allergic reactions to multiple foods following an accidental exposure
The plant is yet to start commercial operations
Transaction delivers KarXT, a first-in-class M1/ M4 muscarinic receptor agonist with differentiated efficacy and safety
This PAI-cum-GMP USFDA inspection was conducted from December 14 to December 22, 2023
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
His most recent stint was with Danone India as its Managing Director
Subscribe To Our Newsletter & Stay Updated
